Relief Therapeutics Holding AG (RLF.SW)
CHF 4.1
(-6.82%)
CHF 4.1
(-6.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -17.51 Million | -24.1 Million | -35.71 Million | -18.23 Million | -748 Thousand | -618 Thousand |
| Net Income | -98.18 Million | -50.79 Million | -34.7 Million | -7.82 Million | -7.46 Million | -436 Thousand |
| Depreciation & Amortization | 3.31 Million | 3.86 Million | 2.03 Million | 112 Thousand | 1000.00 | 17 Thousand |
| Deferred income taxes | -13.5 Million | -3.52 Million | -820 Thousand | 1.56 Million | -4.71 Million | 139 Thousand |
| Stock-based compensation | 814 Thousand | 2.18 Million | 1.14 Million | 1.04 Million | - | 19 Thousand |
| Change in working capital | -991 Thousand | 5.59 Million | -5.23 Million | 5000.00 | 17 Thousand | -158 Thousand |
| Other non-cash items | 99.27 Million | 18.57 Million | 1.86 Million | -13.13 Million | 11.18 Million | -199 Thousand |
| Investing Cash Flow | 8.6 Million | -8.01 Million | -30.26 Million | 3 Million | - | - |
| Investments in PPE | -446 Thousand | -521 Thousand | -13.7 Million | - | - | - |
| Acquisitions | - | -7.92 Million | -16.67 Million | -16 Thousand | - | - |
| Investment purchases | -5000.00 | -38 Thousand | -23 Thousand | - | - | - |
| Sales/Maturities of investments | - | 462 Thousand | 132 Thousand | 3.26 Million | - | - |
| Other Investing Activities | 9.05 Million | 1.00 | -13.58 Million | -241 Thousand | - | - |
| Financing Cash Flow | 4.05 Million | 6.41 Million | 67.68 Million | 58.18 Million | 620 Thousand | 748 Thousand |
| Debt repayment | -20 Thousand | -81 Thousand | -5.55 Million | -480 Thousand | -620 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -494 Thousand | -223 Thousand | -2.84 Million | -634 Thousand | - | - |
| Common Stock Issuance | 5.09 Million | 7.11 Million | 76.08 Million | 58.33 Million | - | 748 Thousand |
| Other Financing Activities | -494 Thousand | 6.41 Million | 67.68 Million | 59.16 Million | 1.24 Million | 748 Thousand |
| Accounts receivables | 129 Thousand | -19 Thousand | -208 Thousand | - | - | - |
| Accounts payables | -599 Thousand | -75 Thousand | -823 Thousand | 1.16 Million | 225 Thousand | -369 Thousand |
| Inventory | -330 Thousand | 164 Thousand | -111 Thousand | - | - | - |
| Other working capital | -191 Thousand | 5.52 Million | -4.09 Million | -1.15 Million | -208 Thousand | 211 Thousand |
| Cash at beginning of period | 19.23 Million | 44.76 Million | 43.15 Million | 129 Thousand | 265 Thousand | 135 Thousand |
| Cash at end of period | 14.55 Million | 19.23 Million | 44.76 Million | 43.15 Million | 129 Thousand | 265 Thousand |
| Capital Expenditure | -446 Thousand | -521 Thousand | -13.7 Million | - | - | - |
| Effect of forex changes on cash | 186 Thousand | 184 Thousand | -102 Thousand | 66 Thousand | - | - |
| Net cash flow / Change in cash | -4.68 Million | -25.52 Million | 1.6 Million | 43.02 Million | -136 Thousand | 130 Thousand |
| Free Cash Flow | -17.96 Million | -24.62 Million | -49.41 Million | -18.23 Million | -748 Thousand | -618 Thousand |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.55 Million | -41.68 Million | -98.18 Million | -56.49 Million | -50.79 Million | -24.29 Million |
| Depreciation & Amortization | 1.43 Million | 1.61 Million | 3.31 Million | 1.7 Million | 3.86 Million | 1.82 Million |
| Deferred income taxes | 560 Thousand | -5.86 Million | -13.5 Million | -7.64 Million | -3.52 Million | -1.91 Million |
| Stock-based compensation | - | 303 Thousand | 814 Thousand | 511 Thousand | 2.18 Million | 898 Thousand |
| Change in working capital | -398 Thousand | -47 Thousand | -991 Thousand | -944 Thousand | 5.59 Million | 3.54 Million |
| Other non-cash items | 2.08 Million | 43.6 Million | 99.27 Million | 55.66 Million | 18.57 Million | 19.68 Million |
| Investing Cash Flow | -86 Thousand | 8.82 Million | 8.6 Million | -220 Thousand | -8.01 Million | -3.23 Million |
| Investments in PPE | -86 Thousand | -77 Thousand | -446 Thousand | -369 Thousand | -521 Thousand | -389 Thousand |
| Acquisitions | - | - | - | - | -7.92 Million | -7.92 Million |
| Investment purchases | - | -5000.00 | -5000.00 | - | -38 Thousand | -38 Thousand |
| Sales/Maturities of investments | - | - | - | - | 462 Thousand | -7000.00 |
| Other Investing Activities | - | 8.9 Million | 9.05 Million | 149 Thousand | 1.00 | 5.12 Million |
| Financing Cash Flow | -616 Thousand | -124 Thousand | 4.05 Million | 4.17 Million | 6.41 Million | 1.75 Million |
| Debt repayment | -345 Thousand | -16 Thousand | -20 Thousand | -4000.00 | -81 Thousand | -81 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -7000.00 | -494 Thousand | -487 Thousand | -223 Thousand | -145 Thousand |
| Common Stock Issuance | - | 85 Thousand | 5.09 Million | 5 Million | 7.11 Million | 2.11 Million |
| Other Financing Activities | -271 Thousand | -124 Thousand | -494 Thousand | 4.52 Million | 6.41 Million | 1.75 Million |
| Accounts receivables | 214 Thousand | -172 Thousand | 129 Thousand | 301 Thousand | -19 Thousand | -4.68 Million |
| Accounts payables | 266 Thousand | -1.17 Million | -599 Thousand | 577 Thousand | -75 Thousand | 71 Thousand |
| Inventory | 183 Thousand | -107 Thousand | -330 Thousand | -223 Thousand | 164 Thousand | 17 Thousand |
| Other working capital | -1.06 Million | 1.4 Million | -191 Thousand | -1.59 Million | 5.52 Million | 1.66 Million |
| Cash at beginning of period | 14.55 Million | 12.79 Million | 19.23 Million | 19.23 Million | 44.76 Million | 29.87 Million |
| Cash at end of period | 10.72 Million | 14.55 Million | 14.55 Million | 12.79 Million | 19.23 Million | 19.23 Million |
| Capital Expenditure | -86 Thousand | -77 Thousand | -446 Thousand | -369 Thousand | -521 Thousand | -389 Thousand |
| Effect of forex changes on cash | - | 119 Thousand | 186 Thousand | 67 Thousand | 184 Thousand | 241 Thousand |
| Net cash flow / Change in cash | -3.82 Million | 1.76 Million | -4.68 Million | -6.44 Million | -25.52 Million | -10.63 Million |
| Free Cash Flow | -3.17 Million | -7.13 Million | -17.96 Million | -10.83 Million | -24.62 Million | -9.78 Million |
0127
1269
9950
0QNG
JAGRAN
TDBKF